Covid-19: Sputnik V Vaccine to undergo late-stage clinical trials in India | News – Times of India Videos

Oct 17, 2020, 07:22PM ISTSource: TNN

Indian authorities have given nod to Russian Covid-19 vaccine Sputnik V’s trial in the country. According to Russian Direct Investment Fund, that is marketing the vaccine abroad, an adaptive phase II and III human clinical trial involving 1,500 participants will be carried out in India. Once the vaccine gets approval, RDIF will supply 100 million doses to Dr Reddy’s, the Indian firm that is partnering RFID in the trial in India.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *